Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Thyroid Neoplasms 1 Renal Insufficiency, Chronic 1 Prostatic Neoplasms 1 Kidney Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

perflutren 1 finerenone 1 empagliflozin 1 Thalidomide 1 Eplerenone 1 Dexamethasone 1 Bortezomib 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Renal Insufficiency, Chronic × perflutren × Clear all

NCT03907657 2024-05-21

CEUS-VHL

UNC Lineberger Comprehensive Cancer Center

Phase 2 Completed

15 enrolled 7 charts

Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡